LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-1992 | 12-1991 | 03-1991 | 12-1990 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 12,349 | 12,349 | N/A | N/A |
| Marketable Securities | 1,100 | 1,100 | N/A | N/A |
| Other current assets | 188 | 188 | 0 | 0 |
| TOTAL | $13,637 | $13,637 | $N/A | $N/A |
| Non-Current Assets | ||||
| Other Non-Current Assets | 326 | 326 | 0 | 0 |
| TOTAL | $326 | $326 | $N/A | $N/A |
| Total Assets | $15,269 | $15,269 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 221 | 221 | 0 | 0 |
| Accrued Expenses | 179 | 179 | N/A | N/A |
| TOTAL | $400 | $400 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $14 | $14 | $N/A | $N/A |
| Total Liabilities | $414 | $414 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 8 | 8 | N/A | N/A |
| Retained earnings | -11,963 | -11,963 | N/A | N/A |
| Other shareholders' equity | 344 | 344 | 0 | 0 |
| TOTAL | $14,855 | $14,855 | $N/A | $N/A |
| Total Liabilities And Equity | $15,269 | $15,269 | $0 | $0 |